Dianthus Therapeutics | MGTA - Interest Income



Dianthus Therapeutics reported $3.4M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Celltrion KRW 7.53B 1.21B Mar/2025
Dianthus Therapeutics USD 3.4M 587K Jun/2025
IQVIA Holdings USD 10M 1000K Jun/2025
Kangmei Pharma 4.31M 8.34M Sep/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma 139K 42K Jun/2025
Medical Developments International 174K 31K Dec/2024
Moderna USD 81M 9M Jun/2025
Pharma Mar 4.8M 6.4M Dec/2024
Qiagen NV USD 13.86M 1.53M Jun/2025
Revvity USD 10.08M 253K Mar/2025
Sartorius 54.9M 77.1M Mar/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 948K 38K Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.63M 3.55M Mar/2025